Cargando…

Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay

Previous data suggest that lipophilic statins such as fluvastatin and N-bisphosphonates such as zoledronic acid, both inhibitors of the mevalonate metabolic pathway, have anti-cancer effects in vitro and in patients. We have examined the effect of fluvastatin alone and in combination with zoledronic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knight, Louise A, Kurbacher, Christian M, Glaysher, Sharon, Fernando, Augusta, Reichelt, Ralf, Dexel, Susanne, Reinhold, Uwe, Cree, Ian A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642836/ https://www.ncbi.nlm.nih.gov/pubmed/19175937 http://dx.doi.org/10.1186/1471-2407-9-38

Ejemplares similares

Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma
por: Sharma, Sanjay, et al.
Publicado: (2003)

Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy
por: Glaysher, S, et al.
Publicado: (2010)

Activation of the plant mevalonate pathway by extracellular ATP
por: Cho, Sung-Hwan, et al.
Publicado: (2022)

Comparison of assays used for in vitro chemosensitivity testing of human tumours.
por: Salmon, S. E., et al.
Publicado: (1984)

Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer
por: Greenaway, James B., et al.
Publicado: (2016)

A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy.
por: Wilson, J. K., et al.
Publicado: (1990)

A comparison of three assays used for the in vitro chemosensitivity testing of human tumours.
por: Wilson, A. P., et al.
Publicado: (1984)

An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia.
por: Bosanquet, A. G., et al.
Publicado: (1983)

Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay
por: Fehm, Tanja, et al.
Publicado: (2012)

The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours
por: Knight, Louise A, et al.
Publicado: (2004)

Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer
por: Göbel, Andy, et al.
Publicado: (2020)

Chemosensitivity measurements of human tumour cells by soft agar assays are influenced by the culture conditions.
por: Endresen, L., et al.
Publicado: (1985)

Comparison of assays used for in vitro chemosensitivity testing of human tumours: Dr Wilson replies
por: Wilson, A.P.
Publicado: (1984)

A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer
por: Guadagni, Stefano, et al.
Publicado: (2020)

Microsatellite instability and chemosensitivity in solid tumours
por: Cherri, Sara, et al.
Publicado: (2022)

Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
por: Haas, Dorothea, et al.
Publicado: (2006)

Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC)
por: Glaysher, Sharon, et al.
Publicado: (2009)

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2017)

Comparison of two soft-agar methods for assaying chemosensitivity of human tumours in vitro: malignant melanomas.
por: Tveit, K. M., et al.
Publicado: (1981)

Diagnostic value of urinary mevalonic acid excretion in mevalonate kinase deficiency (MKD)
por: Jeyaratnam, Jerold, et al.
Publicado: (2014)

Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells
por: Abdullah, Marwan Ibrahim, et al.
Publicado: (2017)

Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay.
por: Yamaue, H., et al.
Publicado: (1992)

ATP citrate lyase mediated cytosolic acetyl-CoA biosynthesis increases mevalonate production in Saccharomyces cerevisiae
por: Rodriguez, Sarah, et al.
Publicado: (2016)

Gastric cancer--the recognition of a chemosensitive tumour.
por: Cunningham, D.
Publicado: (1988)

Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
por: Durand, R. E., et al.
Publicado: (1987)

The mevalonate pathway in C. Elegans
por: Rauthan, Manish, et al.
Publicado: (2011)

Mevalonate Metabolism in Immuno-Oncology
por: Gruenbacher, Georg, et al.
Publicado: (2017)

Mevalonate kinase somatic mosaicism and bigenic genotypes may explain heterogeneity in mevalonate kinase deficiency
por: Shinar, Y, et al.
Publicado: (2015)

Tumor metabolism regulating chemosensitivity in ovarian cancer
por: Han, Chae Young, et al.
Publicado: (2018)

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
por: Coscia, Marta, et al.
Publicado: (2010)

USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer
por: Maier, Carina R., et al.
Publicado: (2023)

Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours
por: Jenkinson, Michael D., et al.
Publicado: (2006)

Synthesis of Heterologous Mevalonic Acid Pathway Enzymes in Clostridium ljungdahlii for the Conversion of Fructose and of Syngas to Mevalonate and Isoprene
por: Diner, Bruce A., et al.
Publicado: (2017)

Chick Embryo Assay as Chemosensitivity Test for Malignant Glioma
por: Shoin, Katsuo, et al.
Publicado: (1991)

Genomic variations of the mevalonate pathway in porokeratosis
por: Zhang, Zhenghua, et al.
Publicado: (2015)

Tocilizumab for the Treatment of Mevalonate Kinase Deficiency
por: Rafiq, Nadia K., et al.
Publicado: (2018)

The Mevalonate Pathway Is Indispensable for Adipocyte Survival
por: Yeh, Yu-Sheng, et al.
Publicado: (2018)

Mevalonate kinase deficiency: current perspectives
por: Favier, Leslie A, et al.
Publicado: (2016)

ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer
por: Lee, Maria, et al.
Publicado: (2014)

Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines
por: Sawers, L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4cilgvf7koeglfhv3i0fj7gdk2